Roche Diagnostics makes solid start to the year
This article was originally published in Clinica
Executive Summary
Roche’s diagnostics division put in a solid performance during its first fiscal quarter, with its troubled diabetes division “holding up well,” according to Jefferies analyst Jeffrey Holford.